The Cellular Therapy Center combines activities of both a clinical laboratory and a research laboratory. Primarily, this laboratory supports the Dartmouth Hitchcock Bone Marrow Transplant Program, which treats patient with hematological malignancies such as leukemia’s, lymphomas, multiple myeloma and myelodysplastic syndrome. The other function of the laboratory is to support clinical trials in treatment of other malignancies such as melanoma, colon cancer, and renal cell carcinoma.
Our laboratory is directly involved with translational research, bringing cellular based treatments from the research laboratory to the clinical setting to be used in Clinical Trials available to patients. The expansion of cell based therapies offers cancer patients a better chance for a long-term cure and is well integrated with activities of the Norris Cotton Cancer Center.
This laboratory is accredited by the American Association of Blood Banks (AABB), the Foundation for the Accreditation of Cellular Therapy (FACT), the College of American Pathologists (CAP), the Joint Commission as well as being registered with the Food and Drug Administration (FDA). We are a secured class 100,000 laboratory with class 10,000 capabilities. This laboratory strives to achieve highest standards in cell-based therapies and bring them to the patients in need.